Articles
How can researchers navigate the complexity of RNA drug discovery
RNA therapeutics are becoming increasingly complex through chemical modifications, delivery strategies, and diverse RNA modalities such as mRNA, siRNA, ASOs, and circRNA.
What are the challenges in antibody drug discovery — and how can they be addressed
Antibody discovery requires optimization across multiple dimensions, including target engagement, functional activity, immunogenicity, and developability.
What drives successful small-molecule drug discovery today
Small-molecule discovery is evolving beyond traditional approaches, with AI, expanded chemical space, and emerging modalities reshaping how candidates are designed and optimized.
Empowering modern research with electronic lab notebooks
Modern research generates more data than ever — across experiments, protocols, teams, and locations. Traditional paper notebooks can make that information difficult to search, secure, share, and reuse.
Optimize Vaccine Development with Peptones
Peptones support efficient and scalable vaccine manufacturing by improving cell growth, enhancing viral production, and reducing reliance on serum-based media.
Transforming Drug Delivery: Embrace Customized Release through Dispersed Dosage Formats!
Customized release through dispersed dosage formats driving patients acceptance and therapeutic performance
Navigating the drug development pipeline
The expansion in the development and manufacturing of highly potent active pharmaceutical ingredients (HPAPIs) and complex active pharmaceutical ingredients (APIs) has grown tremendously as demands in healthcare to bring newer therapies to market quicker increase.
Navigating an uncertain regulatory environment for mRNA-based products
The development of effective vaccines to combat COVID-19 has showcased the potential of mRNA technology, which is now under exploration for various clinical areas, including oncology, HIV, rare diseases, and personalized medicine.
First shaker to earn the ACT label: Multitron manufactured in Europe
The Multitron incubator shaker, manufactured in Bottmingen Switzerland, is the first shaker to earn the ACT Label (Environmental Impact Factor Label), recognizing its sustainable design and environmental responsibility.
Digital Maturity in Pharma and Medtech Manufacturing
MasterControl’s research on digital maturity in pharmaceutical and medtech manufacturing reveals many companies still rely on manual, paper-based, and siloed systems despite innovations.
